πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

165 results for β€œSunshine” Clear

  1. SSGJ-707

    Sunshine Biopharma

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial
  2. prefilled liquid etanercept(Yisaipu)

    Sunshine Biopharma

    Ankylosing Spondylitis

    phase 3 small molecule completed

    1 trial
  3. rhTPO

    Sunshine Biopharma

    Thrombocytopenia

    phase 3 small molecule active

    1 trial
  4. 601

    Sunshine Biopharma

    Pathological Myopic Choroidal Neovascularization

    phase 2 small molecule active

    1 trial
  5. 601 1.25mg

    Sunshine Biopharma

    Central Retinal Vein Occlusion

    phase 2 small molecule completed

    1 trial
  6. 608

    Sunshine Biopharma

    Axial Spondyloarthritis

    phase 2 small molecule active

    1 trial
  7. 608 Dose A

    Sunshine Biopharma

    Ankylosing Spondylitis

    phase 2 small molecule active

    1 trial
  8. 609A

    Sunshine Biopharma

    Sarcoma, Soft Tissue

    phase 2 small molecule active

    1 trial
  9. 610 100mg

    Sunshine Biopharma

    Asthma

    phase 2 small molecule active

    1 trial
  10. 611 150mg

    Sunshine Biopharma

    Dermatitis, Atopic

    phase 2 small molecule completed

    1 trial
  11. 611 300 mg Q2W

    Sunshine Biopharma

    Pulmonary Disease, Chronic Obstructive

    phase 2 small molecule completed

    1 trial
  12. 611 Q2W

    Sunshine Biopharma

    Dermatitis, Atopic

    phase 2 small molecule completed

    1 trial
  13. 626

    Sunshine Biopharma

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial
  14. 627

    Sunshine Biopharma

    Ulcerative Colitis (UC)

    phase 2 small molecule active

    1 trial
  15. CPGJ602

    Sunshine Biopharma

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    2 trials
  16. CT053PTSA

    Sunshine Biopharma

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial
  17. CT053PTSA

    Sunshine Biopharma

    Renal Cell Cancer Metastatic

    phase 2 small molecule terminated

    1 trial
  18. CT053PTSA

    Sunshine Biopharma

    Advanced NSCLC

    phase 2 small molecule terminated

    1 trial
  19. Clifutinib Besylate

    Sunshine Biopharma

    Acute Myeloid Leukemia, Adult

    phase 2 small molecule active

    1 trial
  20. GLS4

    Sunshine Biopharma

    Chronic Hepatitis B

    phase 2 small molecule completed

    3 trials
  21. GLS4

    Sunshine Biopharma

    Chronic HBV Infection

    phase 2 small molecule completed

    1 trial
  22. HEC110114 tablet

    Sunshine Biopharma

    Chronic Hepatitis C

    phase 2 small molecule completed

    2 trials
  23. HEC121120 tablets

    Sunshine Biopharma

    Hepatitis B, Chronic

    phase 2 small molecule terminated

    1 trial
  24. HEC169096

    Sunshine Biopharma

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources